Methylfolate and Restasis drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylfolate (folic acid) and Restasis (cyclosporine). Common drug interactions include migraine among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Methylfolate and Restasis. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.
What is Methylfolate?
Methylfolate has active ingredients of folic acid. eHealthMe is studying from 1,018 Methylfolate users. Check the latest studies of Methylfolate.
What is Restasis?
Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.
34 people who take Methylfolate and Restasis together, and have interactions are studied.

What are the common drug interactions of Methylfolate and Restasis, by gender? *:
female:
- Migraine (headache)
- Sinusitis (inflammation of sinus)
- Insomnia (sleeplessness)
- Oral fungal infection
- Oedema (fluid collection in tissue)
- Accident at home
- Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
- Fall
- Fatigue (feeling of tiredness)
- Foot fracture
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Cardiac procedure complication
- Malaise (a feeling of general discomfort or uneasiness)
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Spinal fracture (fracture in one of vertebrae)
- Thoracic vertebral fracture
- Bone density decreased
- Depression
- Emotional distress
What are the common drug interactions of Methylfolate and Restasis, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Sinusitis (inflammation of sinus)
- Accident at home
- Infusion related reaction
- Limb injury
- Migraine (headache)
- Nephrolithiasis (calculi in the kidneys)
- Oral fungal infection
- Osteochondrosis (a family of orthopaedic diseases of the joint that occur in children and adolescents)
- Pyrexia (fever)
- Rash pruritic (redness with itching)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 10 people, 29.41%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 26.47%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 20.59%
- Migraine (headache): 6 people, 17.65%
- Primary Immunodeficiency Syndrome: 3 people, 8.82%
- Migraine Without Aura (headache without neurological problems): 3 people, 8.82%
- Immunodeficiency: 3 people, 8.82%
- Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 5.88%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.88%
- Gastric Ulcer (stomach ulcer): 2 people, 5.88%
* Approximation only. Some reports may have incomplete information.
Do you take Methylfolate and Restasis?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylfolate (1,018 reports)
- Restasis (35,199 reports)
Browse all drug interactions of Methylfolate and Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylfolate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Restasis:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylfolate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Restasis and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on folic acid and cyclosporine (the active ingredients of Methylfolate and Restasis, respectively), and Methylfolate and Restasis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Vitamin B12 cause Retinal Vessel Occlusion? - 2 seconds ago
- Drug interactions of Thalidomide and Lamivudine - 4 seconds ago
- Drug interactions of Mestinon and Imuran - 42 seconds ago
- Drug interactions of Pantoprazole Sodium and Rasagiline Mesylate - 53 seconds ago
- Could Zyflo Cr cause Dyspnea? - 58 seconds ago
- Drug interactions of Xyzal and Farxiga - a minute ago
- Could Doxycycline cause Forced Expiratory Volume Decreased? - a minute ago
- Could Pioglitazone cause Nephrogenic Systemic Fibrosis? - a minute ago
- Could Geodon cause Insulin-Requiring Type 2 Diabetes Mellitus? - a minute ago
- Hyperkalemia and Acute Upper Airway Obstruction - a minute ago